Page 323 - Read Online

Shen et al. Evaluation of microRNAs normalization approaches

2014;5:102. 26. Wang X, Gardiner EJ, Cairns MJ. Optimal consistency in microRNA
8. Yang Z, Cappello T, Wang L. Emerging role of microRNAs in lipid expression analysis using reference-gene-based normalization. Mol
metabolism. Acta Pharm Sin B 2015;5:145-50. Biosyst 2015;11:1235-40.
9. Zarfeshani A, Ngo S, Sheppard AM. MicroRNA expression relating to 27. Lin L, Lu B, Yu J, Liu W, Zhou A. Serum miR-224 as a biomarker for
dietary-induced liver steatosis and NASH. J Clin Med 2015;4:1938-50. detection of hepatocellular carcinoma at early stage. Clin Res Hepatol
10. Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W. Gastroenterol 2016;40:397-404.
Dysregulated serum microRNA expression profile and potential 28. Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, Jasmine F, Ahsan
biomarkers in hepatitis C virus-infected patients. Int J Med Sci H, Wu DP, Siegel AB, Remotti H, Santella RM. Exploring genome-
2015;12:590-8. wide DNA methylation profiles altered in hepatocellular carcinoma
11. Shen J, Wang A, Wang Q, Gurvich I, Siegel AB, Remotti H, using Infinium HumanMethylation 450 BeadChips. Epigenetics
Santella RM. Exploration of genome-wide circulating microRNA 2013;8:34-43.
in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. 29. Shen J, LeFave C, Sirosh I, Siegel AB, Tycko B, Santella RM.
Cancer Epidemiol Biomarkers Prev 2013;22:2364-73. Integrative epigenomic and genomic filtering for methylation markers
12. Zhang Z, Ge S, Wang X, Yuan Q, Yan Q, Ye H, Che Y, Lin Y, in hepatocellular carcinomas. BMC Med Genomics 2015;8:28.
Zhang J, Liu P. Serum miR-483-5p as a potential biomarker to detect 30. Shen J, Wang S, Siegel AB, Remotti H, Wang Q, Sirosh I, Santella
hepatocellular carcinoma. Hepatol Int 2013;7:199-207. RM. Genome-wide expression of microRNAs is regulated by DNA
13. Bronte F, Bronte G, Fanale D, Caruso S, Bronte E, Bavetta methylation in hepatocarcinogenesis. Gastroenterol Res Pract
MG, Fiorentino E, Rolfo C, Bazan V, Di Marco V, Russo A. 2015;2015:230642.
HepatomiRNoma: the proposal of a new network of targets for 31. Edge SB, Compton CC. The American Joint Committee on Cancer:
diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit Rev the 7th edition of the AJCC cancer staging manual and the future of
Oncol Hematol 2016;97:312-21. TNM. Ann Surg Oncol 2010;17:1471-4.
14. Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated 32. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
microRNAs in progression of hepatocellular carcinoma: a systematic Paepe A, Speleman F. Accurate normalization of real-time quantitative
review. Hepatol Res 2016;46:391-406. RT-PCR data by geometric averaging of multiple internal control
15. Boisen MK, Dehlendorff C, Linnemann D, Schultz NA, Jensen BV, genes. Genome Biol 2002;3:1-11.
Høgdall EV, Johansen JS. MicroRNA expression in formalin-fixed 33. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time
paraffin-embedded cancer tissue: identifying reference microRNAs quantitative reverse transcription-PCR data: a model-based variance
and variability. BMC Cancer 2015;15:1024. estimation approach to identify genes suited for normalization, applied
16. Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X, Liu J, Jiao X, Du to bladder and colon cancer data sets. Cancer Res 2004;64:5245-50.
Z. Profiles of differential expression of circulating microRNAs in 34. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis
hepatitis B virus-positive small hepatocellular carcinoma. Cancer of gene expression data using BRB-ArrayTools. Cancer Inform
Biomark 2015;15:171-80. 2007;3:11-7.
17. Wong CM, Wong CC, Lee JM, Fan DN, Au SL, Ng IO. Sequential 35. Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R.
alterations of microRNA expression in hepatocellular carcinoma InteractiVenn: a web-based tool for the analysis of sets through Venn
development and venous metastasis. Hepatology 2012;55:1453-61. diagrams. BMC Bioinformatics 2015;16:169.
18. Augello C, Vaira V, Caruso L, Destro A, Maggioni M, Park YN, 36. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches
Montorsi M, Santambrogio R, Roncalli M, Bosari S. MicroRNA and considerations. Nat Rev Genet 2012;13:358-69.
profiling of hepatocarcinogenesis identifies C19MC cluster as a 37. Li ZB, Li ZZ, Li L, Chu HT, Jia M. MiR-21 and miR-183 can
novel prognostic biomarker in hepatocellular carcinoma. Liver Int simultaneously target SOCS6 and modulate growth and invasion of
2012;32:772-82. hepatocellular carcinoma (HCC) cells. Eur Rev Med Pharmacol Sci
19. Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Identification of 2015;19:3208-17.
deregulated miRNAs and their targets in hepatitis B virus-associated 38. Thurnherr T, Mah WC, Lei Z, Jin Y, Rozen SG, Lee CG. Differentially
hepatocellular carcinoma. World J Gastroenterol 2012;18:5442-53. expressed miRNAs in hepatocellular carcinoma target genes in the
20. Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, genetic information processing and metabolism pathways. Sci Rep
Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z. Plasma miRNAs as early 2016;6:20065.
biomarkers for detecting hepatocellular carcinoma. Int J Cancer 39. Huang CS, Yu W, Cui H, Wang YJ, Zhang L, Han F, Huang T.
2015;137:1679-90. Increased expression of miR-21 predicts poor prognosis in patients
21. Oksuz Z, Serin MS, Kaplan E, Dogen A, Tezcan S, Aslan G, Emekdas with hepatocellular carcinoma. Int J Clin Exp Pathol 2015;8:7234-8.
G, Sezgin O, Altintas E, Tiftik EN. Serum microRNAs; miR-30c-5p, 40. Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB,
miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non- Zheng MH, Dong JZ, Zhang L, Chen YP. Hepatocellular carcinoma
invasive biomarkers for HCV-positive cirrhosis and hepatocellular associated microRNA expression signature: integrated bioinformatics
carcinoma. Mol Biol Rep 2015;42:713-20. analysis, experimental validation and clinical significance. Oncotarget
22. Zhuang L, Xu L, Wang P, Meng Z. Serum miR-128-2 serves as a 2015;6:25093-108.
prognostic marker for patients with hepatocellular carcinoma. PLoS 41. Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang
One 2015;10:e0117274. Z. Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
23. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann World J Gastroenterol 2011;17:3353-8.
F, Speleman F, Vandesompele J. A novel and universal method for 42. Yuan R, Zhi Q, Zhao H, Han Y, Gao L, Wang B, Kou Z, Guo Z,
microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64. He S, Xue X, Hu H. Upregulated expression of miR-106a by DNA
24. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.
expression profiles in normal human tissues. BMC Genomics Tumour Biol 2015;36:3093-100.
2007;8:166. 43. Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang Q, Cheng P, Tang
25. Chugh P, Dittmer DP. Potential pitfalls in microRNA profiling. Wiley ZH, Huang F. Meta-analysis of microRNA-183 family expression in
Interdiscip Rev RNA 2012;3:601-16. human cancer studies comparing cancer tissues with noncancerous
314 Hepatoma Research ¦ Volume 2 ¦ November 18, 2016